Home

Bringing gene therapy to the failing heart

Spotlight

Lonza and DiNAQOR AG Announce Strategic Collaboration to Advance Gene Therapy Programs for Patients with Monogenic Cardiomyopathies

DiNAQOR is a global gene therapy platform company focused on advancing novel solutions for patients suffering from heart disease.